Skip to main content

Advertisement

Fig. 6 | Cardiovascular Diabetology

Fig. 6

From: Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains

Fig. 6

Clots from a representative type 2 diabetes individual with added LPS-binding protein (LBP) and ergothioneine, and fluorescent markers. a Naïve T2D clot; b 8 ng L−1 LBP and 250 µM ergothioneine; c 20 ng L−1 LBP and 250 µM ergothioneine d 30 ng L−1 LBP. Fluorescence shown from left to right Amytracker 680 (red), Amytracker 480 (blue) and ThT (green)

Back to article page